Merus

MRUS NASDAQ
18.20
+0.08
+0.44%
Opening 10:28 08/21 EDT
Open
17.97
Prev Close
18.12
High
18.25
Low
17.78
Volume
3.83K
Avg Vol (3M)
34.90K
52 Week High
22.46
52 Week Low
11.00
% Turnover
0.02%
Market Cap
425.76M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Merus MRUS stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Merus NV is a biotechnology company based in the Netherlands. The Company develops differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Biclonics format. Its products include, among others, MCLA-134 that is designed to bind to a combination of two immunomodulatory targets expressed by T cells, as well as MCLA-145 that is designed to bind to a tumor-associated target with an immunomodulatory target involved in checkpoint inhibition.
MORE >

Recently

Name
Price
%Change